Dr. Perales On Car T-Cell Therapy In Dlbcl And Follicular Lymphoma

Dr. Perales on CAR T-Cell Therapy in DLBCL and Follicular Lymphoma

Dr. Perales on the Future of CAR T-Cell Therapy in DLBCL and Follicular Lymphoma

Dr. Perales on Ongoing Studies With CAR T Cells in DLBCL

Dr. Perales on Remaining Questions With CAR T-Cell Therapy in Hematologic Malignancies

CAR T-Cell Therapy in DLBCL: Centers of Excellence

After CAR T Cell Therapy Follicular Lymphoma Patient Has Time On His Side

Dana-Farber Cancer Institute

Dr. Flinn on CAR T-Cell Therapy in Non-Hodgkin Lymphoma

Who Should Receive CAR-T Cell Therapy for Lymphoma?

Clinical outcomes of patients with R/R B-cell ALL receiving CAR-T

VJHemOnc – Video Journal of Hematology & HemOnc

Latest updates in CAR-T therapy for follicular lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Perales on Treatment With Approved CAR T-Cell Therapy

CAR T-Cell Therapy Saved My Life: Robyn's Non-Hodgkin Lymphoma Story | The Patient Story

The Patient Story

Investigating CAR T-Cell Therapy in Lymphoma

CAR T-Cell Therapy for Patients with Lymphoma

Understanding CAR T cell therapy for the treatment of Lymphoma

Lymphoma Australia

Limitations of CAR T-cell therapy for DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

How successful is CAR-T for B-cell lymphoma?

Current & future outlooks on CAR-T therapy & bispecific antibodies in follicular lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL

Outcomes of CAR-T therapy in patients with refractory B-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc